Lexeo Therapeutics, Inc. Common Stock
Lexeo Therapeutics, Inc. Common Stock（LXEO）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
lxeo · 股价预测 · 5 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 5 位华尔街分析师
Buy
5 位分析师
共识
评级分布
12 个月目标价
High
$25.00
Consensus
$18.33
+334.4% upside
Low
$10.00
Median: $20 · Last Close: $4.22
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$18.33
334.4% upside
High Target
$25
492.4%
Low Target
$10
137.0%
Current Price
$4.22
as of today
Based on analyst price targets, the LXEO stock price prediction for the next 12 months ranges from $10 to $25. The consensus LXEO price forecast of $18.33 implies 334.4% upside from the current price of $4.22.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.01 | ↓ 5.00% |
1-day model range: $3.96–$4.06. Peak: $4.06 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $2 | -42.4% |
| 2028 | $2 | -55.9% |
| 2029 | $2 | -61.5% |
| 2030 | $2 | -64.2% |
| 2031 | — | -65.6% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · LXEO · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-11 | Chardan Capital | Maintains | Buy→Buy |
| 2026-01-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-13 | Chardan Capital | Maintains | Buy→Buy |
| 2025-12-11 | Chardan Capital | Maintains | Buy→Buy |
| 2025-11-05 | Chardan Capital | Maintains | Buy→Buy |
| 2025-10-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-07 | Chardan Capital | Maintains | Buy→Buy |
| 2025-10-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-07 | Leerink Partners | Maintains | Outperform→Outperform |
| 2025-08-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Lexeo Therapeutics, Inc. Common Stock (LXEO) stock. Of the recent 35 rating actions, 0 were upgrades and 0 were downgrades. 5 analysts currently cover LXEO.
分析师推荐趋势
LXEO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$9M
EPS This Year
$-1.17
EPS Next Year
$-1.26
↑ 7.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast LXEO EPS of $-1.17 for the current fiscal year, based on estimates from 6 analysts. The LXEO revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
LXEO 股价预测由两类独立数据源支撑：来自 5 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。LXEO 的共识目标价为 $18.33（+334.4% 上行空间），分析师共识为 Buy。
LXEO 的短期预测（明日）为 $4.01（-5.00%）。 LXEO 对 2027 年的股价预测均值为 $2。 LXEO 对 2030 年的预测区间为 $1–$2。
Lexeo Therapeutics, Inc. Common Stock 在 NASDAQ 上市，代码 LXEO。LXEO 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
LXEO 预测 · 8 个问题根据 5 位华尔街分析师，LXEO 的 12 个月平均目标价为 $18.33，最高 $25.00、最低 $10.00。若有图表，中位目标价可在上方查看。相对当前价 $4.22，隐含约 +334.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.